SamaCare Named 2026 Prix Galien Finalist for Specialty Care Innovation

For patients diagnosed with conditions ranging from cancer to autoimmune and neurologic diseases, the path from prescription to treatment is often obstructed by a thicket of administrative hurdles. Requirements such as benefits verification, payer reviews, and complex appeals frequently delay care, leading to worsening health outcomes and increased anxiety. SamaCare was built to dismantle these barriers by transforming fragmented prior authorization workflows into a unified, intelligent system.

The platform integrates workflow automation with payer policy intelligence to help specialty practices anticipate requirements and minimize denials. By streamlining the process for provider-administered medications, the company reduces the staff burden that often detracts from direct patient care. According to Founder and CEO Syam Palakurthy, the platform’s value lies in solving the "operational path" between a physician’s decision and the patient receiving the necessary medicine.

Beyond immediate workflow relief, the system generates real-world data that provides life sciences teams with visibility into the specific friction points patients encounter. This intelligence enables more targeted provider support and clearer insights into access barriers. As the industry marks the 20th anniversary of the Prix Galien USA Awards, SamaCare’s inclusion reflects a shift toward prioritizing practical, AI-driven solutions that directly improve the speed and reliability of medical treatment access.